Literature DB >> 31146911

CXCL1 promotes the proliferation of neural stem cells by stimulating the generation of reactive oxygen species in APP/PS1 mice.

Yu Shang1, Li Tian2, Tianjiao Chen1, Xiaoying Liu1, Jilin Zhang1, Dongxin Liu1, Jiayi Wei1, Wengang Fang1, Yuhua Chen3, Deshu Shang4.   

Abstract

PURPOSE: Elevated levels of CXCL1 were observed in the cerebrospinal fluid of patients with early Alzheimer's disease, which may affect neural stem cells in the subventricular zone. We used APP/PS1 mice and neural stem cells to elucidate the role of CXCL1 in Alzheimer's disease. METHODS &
RESULTS: We detected CXCL1 in cerebrospinal fluid (CSF), activated macrophages, and microglia suggesting that macrophages may contribute to elevated CXCL1 in the CSF of middle-aged APP/PS1 mice. Proliferation and differentiation of neural stem cells were further analyzed and the results suggested that CXCL1 promotes the proliferation of neural stem cells and inhibits their differentiation into astrocytes. In order to determine how CXCL1 exerts these effects, we analyzed intracellular reactive oxygen species, cell signaling, and performed in vivo recovery experiments. Our results suggest that CXCL1 promotes neural stem cell proliferation through a mechanism involving the production of reactive oxygen species and the PI3K/Akt pathway.
CONCLUSION: In APP/PS1 mice, macrophage-derived CXCL1 can promote the proliferation of neural stem cells in the subventricular zone via the NOX2-ROS-PI3K/Akt pathway.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APP/PS1 mice; CXCL1; NOX2; Neural stem cells; PI3K/Akt; Reactive oxygen species

Mesh:

Substances:

Year:  2019        PMID: 31146911     DOI: 10.1016/j.bbrc.2019.05.130

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Chemokine profile in women with moderate to severe anxiety and depression during pregnancy.

Authors:  Ignacio Camacho-Arroyo; Mónica Flores-Ramos; Ismael Mancilla-Herrera; Fausto Moisés Coronel Cruz; Joselin Hernández-Ruiz; Gabriela Pellón Diaz; Blanca Farfán Labonne; María Del Pilar Meza-Rodríguez; Philippe Leff Gelman
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-04       Impact factor: 3.007

Review 2.  The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System.

Authors:  Jan Korbecki; Magdalena Gąssowska-Dobrowolska; Jerzy Wójcik; Iwona Szatkowska; Katarzyna Barczak; Mikołaj Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 3.  Role of Chemokines in the Development and Progression of Alzheimer's Disease.

Authors:  Jakub Wojcieszak; Katarzyna Kuczyńska; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2022-07-12       Impact factor: 2.866

4.  Transforming L1000 profiles to RNA-seq-like profiles with deep learning.

Authors:  Minji Jeon; Zhuorui Xie; John E Evangelista; Megan L Wojciechowicz; Daniel J B Clarke; Avi Ma'ayan
Journal:  BMC Bioinformatics       Date:  2022-09-13       Impact factor: 3.307

5.  The important role of NLRP6 inflammasome in Pasteurella multocida infection.

Authors:  Xingping Wu; Zheng Zeng; Hongliang Tian; Lianci Peng; Dongyi Xu; Yu Wang; Chao Ye; Yuanyi Peng; Rendong Fang
Journal:  Vet Res       Date:  2022-10-12       Impact factor: 3.829

Review 6.  NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.

Authors:  Cinzia Sindona; Giovanni Schepici; Valentina Contestabile; Placido Bramanti; Emanuela Mazzon
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

7.  MicroRNA-429/Cxcl1 Axis Protective Against Oxygen Glucose Deprivation/Reoxygenation-Induced Injury in Brain Microvascular Endothelial Cells.

Authors:  Jun Leng; Wei Liu; Li Li; Fang Yue Wei; Meng Tian; Hui Min Liu; Wen Guo
Journal:  Dose Response       Date:  2020-04-03       Impact factor: 2.658

8.  Cytokines CCL2 and CXCL1 may be potential novel predictors of early bone loss.

Authors:  Yaqian Hu; Long Wang; Zhuojie Zhao; Weiguang Lu; Jing Fan; Bo Gao; Zhuojing Luo; Qiang Jie; Xiaojuan Shi; Liu Yang
Journal:  Mol Med Rep       Date:  2020-09-28       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.